Surely this means the results for 51 & 44 are very positive?
Race is on!
Almost never do I find anything of value on the Yahoo finance message boards.
But here is a nugget that may provide some insight from business POV on what is coming out of GSK. I DO NOT PERSONALLY VOUCH FOR ANY OF THESE STATEMENTS... just thought I would share what may be the first useful exchange of ideas I've seen on Yahoo in many months
I too hope that the big player GSK just gives up the legal struggle and somehow licenses/buys/merges technology from Sarepta. Would save huge on legal fees alone, and the boys are biggest winners.
Thanks for the link David. There's speculation on the message board that Sarepta's compound could be on the market by next summer if they receive accelerated approval. That seems wildly optimistic. Thoughts?